TrialBritish journal of cancer2022

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.

Leonora W de Boo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.